INO-5401

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameINO-5401
Drug Alias NameINO-5401
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsProstate-Specific Membrane Antigen modulators +[5] 
TargetsProstate-Specific Membrane AntigenTelomerase reverse transcriptaseWilms' Tumour 1
Therapy Area/IndicationsCarcinoma, Transitional CellGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesInovio Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional CellGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A